Priv. Doz. Dr. K. Arastéh
Priv. Doz. Dr. K. Arastéh

The success story of EPIMED began in 1997 when it was formed by the Department of Internal Medicine at the Auguste-Viktoria-Klinikum and HIV experts in private practice as a joint site for clinical studies into ART and opportunistic infections. Today EPIMED and its 12 associated practices have more than a decade of experience in conducting phase Ib – IIIb studies, along with investigator-initiated trials, retrospective analyses and pharmacokinetic studies.

While EPIMED started with its initial focus on HIV and HIV-related conditions, we have responded to emerging developments and expanded our expertise into contigous fields of internal medicine and infectioal deseases i.e.hepatitides, vaccinacion studies, STIs.

EPIMED offers an exeptionally high level of cost-effective research and development to our cooperating pharmaceutical companies. The unique structure of our trial site provides us with direct access to approximately 5,000 patients with HIV/AIDS and approximately 1,000 with viral hepatitis, and we are able to maintain the highest standards regarding both quality and quantity when recruiting participants.

In specific cases and when Screening and Baseline are completed at EPIMED central unit in Auguste-Viktoria-Klinikum, the participants in our phase II/III trials may subsequently do their visits in the peripheral units in the associated practices. Our standard operating procedures (SOP) provide detailed guidelines and limitations that regulate everything from screening visits to SAE reporting. These procedures are subject to continuous monitoring and revision in accordance with the requirements of GCP and Germany’s legislation on pharmaceutical trials.

We passed more than 11 audits of clients, local authorities and a FDA-inspection in 2014. The latter concluded, that we adhere all FDA requirements for the counduction of clinical trials and the protection of human subjects. With our well-equipped study site and our extensive experience, we can guarantee data of excellent quality for the research and approval of pharmaceutical products. EPIMED provides an ideal base of dedicated research professionals and participant recruitment with efficient central monitoring.

At EPIMED, patients’ safety and rights are always of central importance to our work.

Fore more information about EPIMED simply contact us by phone or write to us using our contact form. We look forward to hearing from you

Keikawus Arastéh


Last change: 02/21/2018